达里多雷克桑的夜间安全性:对外部噪音刺激的反应能力,姿势稳定性,行走和认知功能的评估
Massimo Magliocca1,2,3, Ingrid Koopmans1,2, Cedric Vaillant4
1Centre for Human Drug Research, Leiden, The Netherlands.
Journal of psychopharmacology (Oxford, England)
|December 6, 2024
概括
治疗失眠的达里多雷克桑 (Daridorexant) 并没有影响听觉唤醒值或认知功能. 它引起了身体摇摆的轻微增加,主要是年轻人,但允许一夜之间安全运作.
科学领域:
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
- 神经科学是一个神经科学.
背景情况:
- 达里多雷克桑 (Daridorexant) 是一种双素受体对抗剂,用于慢性失眠障碍.
- 了解它对夜间功能的影响对于患者安全至关重要.
研究的目的:
- 评估睡前达里多雷克桑 (25和50毫克) 对听觉觉醒值 (AAT),姿势稳定性和认知功能的影响.
- 为了评估daridorexant在夜间时间的安全性和药理动力学影响.
主要方法:
- 这是一项双盲,安慰剂控制,随机交叉研究,涉及36名健康成年人.
- 评估包括AAT,夜间姿势稳定性 (身体摇摆),定时启动和启动 (TUG) 测试,以及睡前给药后的视觉语言学习测试 (VVLT).
主要成果:
- 达里多雷克桑没有影响AAT或认知功能 (VVLT),与安慰剂相比,显示的差异很小.
- 身体摇摆的边际增加 (约. 22%),主要在非老年人中观察到,而老年人则表现出与安慰剂相似的效应.
- 没有发现对功能移动性 (TUG测试) 有临床意义的影响.
结论:
- 睡前服用达里多雷克桑特可以使个体保持对听觉刺激的唤醒能力.
- 药物对于夜间功能似乎是安全的,在关键的安全性和认知参数中没有显著的损害.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
REM Sleep Behavior Disorder
145
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
145
Restless Leg Syndrome and Night Terrors
150
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
150
Narcolepsy
89
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
89


